ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes Grant

ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes Grant

Status: ACTIVE
Funder: American Society of Hematology Inc
Amount: Up to US $5,000
Last Updated: June 23, 2025

Summary

The ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes recognizes outstanding research in MDS by trainees. This prestigious award, offered by the American Society of Hematology, grants $4,000 and a $1,000 travel allowance for in-person presentation at the annual meeting. Eligible applicants must be first authors of the highest-scoring abstracts, with a focus on older populations. This initiative aims to promote research excellence and support emerging scientists in the field of hematology.

Overview

The ASH-Frank Toohey Abstract Achievement Award for Myelodysplastic Syndromes (MDS) is part of the ASH Abstract Achievement Award program. This annual award shall be granted to a trainee (undergraduate student, medical student, graduate student, resident physician, or post-doctoral (MD or PhD) fellow) who is the first author and presenter of the highest-scoring abstract submitted in the field of MDS, with a preference for highly rated abstracts relating to older populations, when available. The recipient shall receive a $4,000 award. Awardees also receive a $1,000 travel allowance for travel to the annual meeting* and complimentary registration to the current year’s ASH annual meeting. Travel allowance is contingent on presenting in person at the annual meeting and is not applicable for virtual presentations.

Eligibility

You can learn more about this opportunity by visiting the funder's website. To be eligible for this award, you must apply the MDS content tag (located under Diseases/Myeloid Malignancies/Chronic Myeloid Malignancies) to your abstract. Special consideration will be given to those abstracts that also apply the “elderly” content tag (located under Study Population/Human).